Lorenzo Colarossi
Overview
Explore the profile of Lorenzo Colarossi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basilotta R, Casili G, Mannino D, Filippone A, Lanza M, Capra A, et al.
iScience
. 2024 Oct;
27(10):110796.
PMID: 39398237
Anaplastic thyroid carcinoma (ATC) is the most aggressive type of thyroid cancer, characterized by rapid growth and invasion and poor prognosis. Due to its rarity and aggressive nature, ATC is...
2.
Campolo M, Scuderi S, Filippone A, Bova V, Lombardo S, Colarossi L, et al.
Pharmaceuticals (Basel)
. 2024 Aug;
17(8).
PMID: 39204206
Oral squamous cell carcinoma (OSCC) is one of the most common human malignancies worldwide. The molecular mechanisms of OSCC pathogenesis are still unknown; however, in recent years, several reports have...
3.
Angelico G, Attanasio G, Colarossi L, Colarossi C, Montalbano M, Aiello E, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893181
AT-rich interaction domain 1 () is a pivotal gene with a significant role in gastrointestinal tumors which encodes a protein referred to as BAF250a or SMARCF1, an integral component of...
4.
Repici A, Ardizzone A, Luca F, Colarossi L, Prestifilippo A, Pizzino G, et al.
Cells
. 2024 Feb;
13(4.
PMID: 38391974
Brain tumors are a diverse collection of neoplasms affecting the brain with a high prevalence rate in people of all ages around the globe. In this pathological context, glioblastoma, a...
5.
Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M, et al.
Nat Commun
. 2023 Mar;
14(1):1351.
PMID: 36906579
Thyroid carcinoma (TC) is the most common malignancy of endocrine organs. The cell subpopulation in the lineage hierarchy that serves as cell of origin for the different TC histotypes is...
6.
Basilotta R, Lanza M, Filippone A, Casili G, Mannino D, De Gaetano F, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36769105
Oral squamous cell carcinoma (OSCC) is a common human tumor, that originates from buccal mucosa and the tongue, associated with a high mortality rate. Currently, the treatment for OSCC involves...
7.
Casili G, Lanza M, Filippone A, Caffo M, Paterniti I, Campolo M, et al.
J Pers Med
. 2022 Dec;
12(12).
PMID: 36556190
Gliomas are relatively rare but fatal cancers, and there has been insufficient research to specifically evaluate the role of headache as a risk factor. Nowadays, gliomas are difficult to cure...
8.
Filippone A, Mannino D, Casili G, Lanza M, Paterniti I, Cuzzocrea S, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555334
High-grade brain tumors are malignant tumors with poor survival and remain the most difficult tumors to treat. An important contributing factor to the development and progression of brain tumors is...
9.
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy
Lo Iacono M, Gaggianesi M, Bianca P, Brancato O, Muratore G, Modica C, et al.
J Clin Med
. 2022 Dec;
11(23).
PMID: 36498571
In a scenario where eco-sustainability and a reduction in chemotherapeutic drug waste are certainly a prerogative to safeguard the biosphere, the use of natural products (NPs) represents an alternative therapeutic...
10.
Scuderi S, Filippone A, Basilotta R, Mannino D, Casili G, Capra A, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430394
Glioblastoma (GB) is a tumor of the central nervous system characterized by high proliferation and invasiveness. The standard treatment for GB includes radiotherapy and chemotherapy; however, new therapies are needed....